TScan Therapeutics (TCRX) Stock Chart & Stock Price History $2.05 +0.01 (+0.49%) Closing price 02/14/2025 04:00 PM EasternExtended Trading$2.04 0.00 (-0.24%) As of 02/14/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TScan Therapeutics Stock Price Performance 5 Day Performance-2.84%1 Month Performance-14.58%3 Month Performance-53.51%6 Month Performance-64.29%Year-To-Date Performance-32.57%1 Year Performance-69.76% Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address TCRX Stock Chart for Monday, February, 17, 2025 TCRX Chart by TradingView TScan Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/14/2025$2.04$2.05+0.49%$2.15$2.03263,712 shs$109.41 million02/13/2025$2.11$2.04-3.32%$2.13$2.02318,373 shs$108.88 million02/12/2025$2.08$2.11+1.44%$2.15$2.03237,160 shs$112.61 million02/11/2025$2.14$2.08-2.80%$2.18$2.04327,968 shs$111.01 million02/10/2025$2.18$2.14-1.83%$2.19$2.10235,703 shs$114.21 million02/07/2025$2.37$2.18-8.02%$2.38$2.18256,104 shs$116.35 million02/06/2025$2.45$2.37-3.27%$2.49$2.35177,628 shs$126.49 million02/05/2025$2.43$2.45+0.82%$2.52$2.42147,555 shs$130.76 million02/04/2025$2.43$2.43$2.55$2.36273,303 shs$129.69 million02/03/2025$2.57$2.43-5.45%$2.67$2.41302,046 shs$129.69 million Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/31/2025$2.58$2.57-0.39%$2.66$2.53218,891 shs$137.16 million01/30/2025$2.50$2.58+3.20%$2.64$2.47152,346 shs$137.70 million01/29/2025$2.48$2.50+0.81%$2.56$2.46117,262 shs$133.43 million01/28/2025$2.45$2.48+1.22%$2.51$2.39131,306 shs$132.36 million01/27/2025$2.52$2.45-2.78%$2.62$2.43190,971 shs$130.76 million01/24/2025$2.56$2.52-1.56%$2.62$2.49174,132 shs$134.49 million01/23/2025$2.52$2.56+1.59%$2.57$2.46125,698 shs$136.63 million01/22/2025$2.37$2.52+6.33%$2.59$2.35350,419 shs$134.49 million01/21/2025$2.40$2.37-1.25%$2.45$2.31383,796 shs$126.49 million01/20/2025$2.40$2.40$2.50$2.38236,538 shs$128.09 million01/17/2025$2.46$2.40-2.44%$2.50$2.38236,538 shs$128.09 million01/16/2025$2.65$2.46-7.17%$2.64$2.44187,693 shs$131.29 million Related Companies KalVista Pharmaceuticals Stock Chart Organogenesis Stock Chart Eton Pharmaceuticals Stock Chart Sage Therapeutics Stock Chart PureTech Health Stock Chart Arcturus Therapeutics Stock Chart SIGA Technologies Stock Chart ChromaDex Stock Chart Keros Therapeutics Stock Chart ABIVAX Société Anonyme Stock Chart Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRX) was last updated on 2/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.